Taiki Isei

Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients

Yasuhiro Nakamura, Kenjiro Namikawa, Kenji Yoshino et al. · Annals of Oncology · 2020 · 140 citations

Medicine, Clinical Sciences, Oncology +17

Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma

Naoya Yamazaki, Yoshio Kiyohara, Hisashi Uhara et al. · Cancer Science · 2017 · 126 citations · Full text

Medicine, Oncology, Pharmacology +17

The wound/burn guidelines – 6: Guidelines for the management of burns

Yuichiro Yoshino, Mikio Ohtsuka, Masakazu Kawaguchi et al. · The Journal of Dermatology · 2016 · 78 citations · Full text

Medicine, Surgery, Burn Surgery +10

Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)

Yasuhiro Nakamura, Kenjiro Namikawa, Shusuke Yoshikawa et al. · ESMO Open · 2021 · 57 citations · Full text

Medicine, Immunology, Oncology +17

Treatment of acquired perforating dermatosis with narrowband ultraviolet B

Shuichi Ohe, Kiichiro Danno, Hiroko Sasaki et al. · Journal of the American Academy of Dermatology · 2004 · 50 citations

Medicine, Dermatology, Cosmetic Dermatology +8